APA (7th ed.) Citation

TL, W., A, R., JG, L., M, V., K, H., AL, C., . . . HT, K. (2017). A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer. Clinical breast cancer, 17(7), 503. https://doi.org/10.1016/j.clbc.2017.04.010

Chicago Style (17th ed.) Citation

TL, Werner, et al. "A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer." Clinical Breast Cancer 17, no. 7 (2017): 503. https://doi.org/10.1016/j.clbc.2017.04.010.

MLA (9th ed.) Citation

TL, Werner, et al. "A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer." Clinical Breast Cancer, vol. 17, no. 7, 2017, p. 503, https://doi.org/10.1016/j.clbc.2017.04.010.